RecruitingPhase 1NCT07156565
Actinium Therapy for Late-stage Aggressive Sarcomas
Studying Soft tissue sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ratio Therapeutics, Inc.
- Intervention
- [Ac 225]RTX-2358(drug)
- Enrollment
- 30 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2032
Study locations (6)
- UCLA, Los Angeles, California, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Memorial Sloane Kettering Cancer Center, New York, New York, United States
- Case Western, Cleveland, Ohio, United States
- MD Anderson Cancer Center, Houston, Texas, United States
- Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07156565 on ClinicalTrials.govOther trials for Soft tissue sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07402577Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility StudyRoswell Park Cancer Institute
- RECRUITINGNANCT07359911Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma PatientsUniversity of Miami
- RECRUITINGNCT07148193Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)Technische Universität Dresden
- RECRUITINGNANCT07104955Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and SafetySalutare Group Ltd.
- RECRUITINGPHASE1, PHASE2NCT07064018Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesUniversity of California, Irvine
- RECRUITINGNCT06962072Outcomes Following Limb Sparing Surgery for Soft Tissue SarcomaAmsterdam UMC
- RECRUITINGPHASE2NCT06905132Preoperative 5-Day Radiotherapy for Soft Tissue SarcomaMedical University of South Carolina
- RECRUITINGPHASE2NCT06593899The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the ExtremitiesFujian Medical University Union Hospital